# Do you stop a GLP-1 before surgery?

Source: https://pepvault.app/guides/glp-1-before-surgery

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?

Reviewed November 2026 18 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Most people no longer stop a GLP-1 before surgery. What the labels, the 2024 multi-society guidance and the 2025 SPAQI consensus say, and when to restart.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 18
- **Questions:** 7
- **Compounds:** 2

## The short answer

As of November 2026, most people do not stop. The 2024 multi-society guidance and the 2025 SPAQI consensus keep most patients on their weekly shot and protect the stomach instead, often with a clear-liquid day before anesthesia. A hold, usually a week, is kept for some higher-risk cases. Tell your surgical team the drug, the dose and your last shot day, and follow their plan.

Every number checked at its primary source · Nov 20, 2026 · [18 sources](https://pepvault.app/guides/glp-1-before-surgery#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Guidance and consensus, not trials: the four FDA labels, the ASA 2023 consensus, the 2024 multi-society guidance and the 2025 SPAQI Delphi consensus; behind them, observational studies in people (gastric ultrasound and endoscopy studies of food left in the stomach, and two large database studies of aspiration and breathing complications). There are no randomised trials on stopping or continuing.

## Why does a GLP-1 matter for anesthesia?

Because these drugs slow the stomach. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) delay **gastric emptying**, the speed at which food leaves the stomach[1](https://pepvault.app/guides/glp-1-before-surgery#source-1) [2](https://pepvault.app/guides/glp-1-before-surgery#source-2) [3](https://pepvault.app/guides/glp-1-before-surgery#source-3) [4](https://pepvault.app/guides/glp-1-before-surgery#source-4). Under general anesthesia or deep sedation the reflexes that guard the airway are off, so food left in the stomach can come up and be breathed into the lungs. That is **pulmonary aspiration**.

All four US labels carry the same warning: Wegovy and Ozempic in section 5.10, Mounjaro and Zepbound in 5.9. It reports "rare postmarketing reports" of aspiration in people who had food left in the stomach "despite reported adherence to preoperative fasting recommendations", says the data are insufficient to tell whether a changed fast or a pause would lower the risk, and gives one instruction: tell your providers before any planned procedure that you take the drug[1](https://pepvault.app/guides/glp-1-before-surgery#source-1) [2](https://pepvault.app/guides/glp-1-before-surgery#source-2) [3](https://pepvault.app/guides/glp-1-before-surgery#source-3) [4](https://pepvault.app/guides/glp-1-before-surgery#source-4).

The effect fades. The tirzepatide labels say the delay is largest after the first dose and shrinks over time[3](https://pepvault.app/guides/glp-1-before-surgery#source-3) [4](https://pepvault.app/guides/glp-1-before-surgery#source-4), and the 2023 anesthesia guidance noted the same with long-term use[5](https://pepvault.app/guides/glp-1-before-surgery#source-5). So the newer guidance looks hardest at people who have just started or stepped up a dose.

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

PepVault logs each shot on its day with the dose you took, and its Doctor's report lists each compound's current dose and schedule, so your last shot day and dose are on your phone when the pre-op nurse asks.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What did the studies find in the stomach?

Most studies looked straight into the stomach, with the endoscope or with a quick ultrasound scan (gastric ultrasound) just before anesthesia, in people who had fasted by the usual rules.

| Study | Who | Stomach not empty (food or extra fluid): on the drug | Not on the drug |
| --- | --- | --- | --- |
| Silveira 2023, endoscopy records | 404 adults, 33 of them on semaglutide in the past 30 days | 24.2% | 5.1%[10](https://pepvault.app/guides/glp-1-before-surgery#source-10) |
| Sen 2024, gastric ultrasound | 124 adults, half on weekly GLP-1 drugs | 56% | 19%[11](https://pepvault.app/guides/glp-1-before-surgery#source-11) |
| Nersessian 2024, gastric ultrasound | 220 adults, 107 on semaglutide in the past 10 days | 40% | 3%[12](https://pepvault.app/guides/glp-1-before-surgery#source-12) |
| Vlaeminck 2026, gastric ultrasound, matched for age, weight and diabetes | 88 adults, 44 on semaglutide | 49% | 18%[13](https://pepvault.app/guides/glp-1-before-surgery#source-13) |
| Boudreau 2026, gastric ultrasound, drug held at least 7 days | 93 adults, weekly GLP-1 drugs | 42% | 24% (not statistically significant; the study was small)[14](https://pepvault.app/guides/glp-1-before-surgery#source-14) |

Food in the stomach is a risk factor, not an aspiration, and counts of actual aspiration are calmer. In a BMJ study of 43,365 adults with type 2 diabetes having an upper endoscopy, aspiration happened in 4.15 per 1,000 GLP-1 users and 4.26 per 1,000 users of another diabetes drug class; the endoscopy was stopped more often on a GLP-1, 9.79 against 4.91 per 1,000, possibly because of food in the stomach[17](https://pepvault.app/guides/glp-1-before-surgery#source-17). In 23,679 people with diabetes having emergency surgery, too soon to hold any drug, breathing complications were 3.5% with a GLP-1 and 4.0% without, no difference after adjustment[18](https://pepvault.app/guides/glp-1-before-surgery#source-18).

Aspiration is rare in any surgery, 0.02% to 0.07% of patients by SPAQI's count[7](https://pepvault.app/guides/glp-1-before-surgery#source-7), so even large studies struggle to show a difference. The societies act on the fuller stomach and plan for it.

## What changed from the 2023 advice to now?

In June 2023 the American Society of Anesthesiologists (ASA) told everyone on a weekly GLP-1 to consider holding it for a week before an elective procedure, whatever the reason for taking it, the dose or the surgery[5](https://pepvault.app/guides/glp-1-before-surgery#source-5). Since then the advice has turned. A 2026 review of the five main guidance documents published since 2023 found that four of them now keep the drug going and change the fast instead, replacing the 2023 hold-for-everyone policy[8](https://pepvault.app/guides/glp-1-before-surgery#source-8). The ASA's own page for patients, reviewed in October 2025, says most patients can keep taking the drug as usual[9](https://pepvault.app/guides/glp-1-before-surgery#source-9).

| Point | ASA, June 2023 | Multi-society, October 2024 | SPAQI, 2025 |
| --- | --- | --- | --- |
| Who wrote it | The ASA's fasting task force[5](https://pepvault.app/guides/glp-1-before-surgery#source-5) | ASA, AGA, ASMBS, ISPCOP and SAGES: the anesthesia, gut, obesity-surgery, obesity-care and endoscopic-surgery societies[6](https://pepvault.app/guides/glp-1-before-surgery#source-6) | SPAQI, a perioperative-medicine society, after a systematic review[7](https://pepvault.app/guides/glp-1-before-surgery#source-7) |
| Keep taking it? | Consider holding: daily drugs on the day, weekly drugs for a week[5](https://pepvault.app/guides/glp-1-before-surgery#source-5) | Yes, unless the risk factors below are present; decided together by you, the surgical, anesthesia and prescribing teams[6](https://pepvault.app/guides/glp-1-before-surgery#source-6) | Yes, unless you have significant stomach symptoms[7](https://pepvault.app/guides/glp-1-before-surgery#source-7) |
| If it is held | A week for weekly shots[5](https://pepvault.app/guides/glp-1-before-surgery#source-5) | The right length is unknown; a week for weekly, the day of for daily[6](https://pepvault.app/guides/glp-1-before-surgery#source-6) | Not held without significant symptoms; those go back to the prescriber first[7](https://pepvault.app/guides/glp-1-before-surgery#source-7) |
| Food and drink before | The usual ASA fasting rules[5](https://pepvault.app/guides/glp-1-before-surgery#source-5) | A liquid diet for at least 24 hours when there is concern[6](https://pepvault.app/guides/glp-1-before-surgery#source-6) | Clear liquids only for 24 hours; sugary clear drinks stop 8 hours before, low-sugar ones 4 hours before[7](https://pepvault.app/guides/glp-1-before-surgery#source-7) |
| On the day | Symptoms: consider delaying; not held: treat as a full stomach or scan it[5](https://pepvault.app/guides/glp-1-before-surgery#source-5) | Ask about symptoms; scan if in doubt; adjust the anesthetic or reschedule[6](https://pepvault.app/guides/glp-1-before-surgery#source-6) | A scan for people with symptoms or who skipped the diet[7](https://pepvault.app/guides/glp-1-before-surgery#source-7) |
| Restarting | Not covered[5](https://pepvault.app/guides/glp-1-before-surgery#source-5) | Not covered[6](https://pepvault.app/guides/glp-1-before-surgery#source-6) | When you are back on your usual diet[7](https://pepvault.app/guides/glp-1-before-surgery#source-7) |

The multi-society document's reasons not to stop everyone: a pause can push blood sugar up in diabetes, bridging to another drug costs money and brings risks such as low blood sugar, and holding a drug only because someone has obesity would be obesity bias[6](https://pepvault.app/guides/glp-1-before-surgery#source-6). It calls itself guidance, not an evidence-based guideline, built on pharmacology and clinical experience[6](https://pepvault.app/guides/glp-1-before-surgery#source-6).

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)

## Who is at higher risk of a full stomach?

The multi-society guidance names five things that raise the chance of a slow stomach on the day[6](https://pepvault.app/guides/glp-1-before-surgery#source-6):

- The escalation phase, the weeks of stepping up to the full dose, more than the steady maintenance phase.
- A higher dose.
- A weekly drug rather than a daily one.
- Stomach symptoms: nausea, vomiting, stomach pain, indigestion or constipation.
- Other conditions that slow the gut, such as gastroparesis or Parkinson's disease.

The ASA's patient page adds timing: escalation usually lasts four to eight weeks, and for a planned operation it is best to wait until it is over[9](https://pepvault.app/guides/glp-1-before-surgery#source-9). SPAQI draws its line at significant symptoms, meaning severe nausea, vomiting or being unable to keep food down, not fullness[7](https://pepvault.app/guides/glp-1-before-surgery#source-7).

**When to get help** If you have nausea, vomiting, bloating or stomach pain in the days before a procedure, call the surgical team before you come in; all three guidances treat these as a reason to change the plan[5](https://pepvault.app/guides/glp-1-before-surgery#source-5) [6](https://pepvault.app/guides/glp-1-before-surgery#source-6) [7](https://pepvault.app/guides/glp-1-before-surgery#source-7).

## Does holding the shot for a week empty the stomach?

Not reliably. The reason is the **half-life**, the time it takes for half the drug to leave the blood. Semaglutide's is about one week, and it stays in circulation for about 5 to 7 weeks after the last shot[1](https://pepvault.app/guides/glp-1-before-surgery#source-1); tirzepatide's is about 5 days, 5 to 6 in people with obesity[3](https://pepvault.app/guides/glp-1-before-surgery#source-3) [4](https://pepvault.app/guides/glp-1-before-surgery#source-4). So a week after the last shot about half the semaglutide is still there, and about 40% of the tirzepatide. The chart shows how tirzepatide builds up and falls on a weekly schedule.

Try it

How Tirzepatide builds up

An estimate from a half-life of about 5 days, one dose a week for four weeks. The shape of the level, not a measurement.

[Try your own schedule](https://pepvault.app/tools/peptide-half-life-calculator) [Tirzepatide in the library](https://pepvault.app/peptides/tirzepatide)

The studies agree. In Sen's study the length of the break made no difference[11](https://pepvault.app/guides/glp-1-before-surgery#source-11); in Silveira's, people with and without food left had stopped semaglutide for about the same time, 10.5 and 10.2 days on average[10](https://pepvault.app/guides/glp-1-before-surgery#source-10); in Boudreau's, 42% still had food after a hold of at least a week[14](https://pepvault.app/guides/glp-1-before-surgery#source-14). A Mayo Clinic study of 316 people linked holds of 7.5 days or less to fuller stomachs, and also solid-food fasts of 21.3 hours or less[15](https://pepvault.app/guides/glp-1-before-surgery#source-15). A Detroit study of 337 endoscopies found that fasting from solids for more than 15 hours cut the odds of food in the stomach by about two-thirds, while a hold of under a week made no clear difference[16](https://pepvault.app/guides/glp-1-before-surgery#source-16). In both, a longer solid-food fast went with an emptier stomach, and a fast costs no weeks of treatment.

## What should you tell your surgical team?

The labels' one instruction is to tell them[1](https://pepvault.app/guides/glp-1-before-surgery#source-1) [2](https://pepvault.app/guides/glp-1-before-surgery#source-2) [3](https://pepvault.app/guides/glp-1-before-surgery#source-3) [4](https://pepvault.app/guides/glp-1-before-surgery#source-4), and every guidance builds its plan from what you say. Do it at booking or the pre-operative call, not on the morning, because a liquid-diet day has to start earlier[6](https://pepvault.app/guides/glp-1-before-surgery#source-6).

1. Name the drug and the brand: Ozempic, Wegovy (shot or tablet), Mounjaro, Zepbound or another.
2. Give the dose you are on now, and say whether you are still stepping up or have been on the same dose for a while.
3. Give your last shot day and your usual shot day, so they can see where the operation falls in your week.
4. Mention any nausea, vomiting, bloating, stomach pain or constipation, even if it is mild.
5. If you take it for diabetes, say so and list your other diabetes medicines, since a pause may need a plan for blood sugar[5](https://pepvault.app/guides/glp-1-before-surgery#source-5) [6](https://pepvault.app/guides/glp-1-before-surgery#source-6).
6. Ask who decides whether to keep or hold the dose: the guidance makes it a shared decision between you and the surgical, anesthesia and prescribing teams[6](https://pepvault.app/guides/glp-1-before-surgery#source-6).
7. Follow the fasting instructions you are given to the hour, including a clear-liquid day if they ask for one.

<!--promo-->

PepVault logs each shot on its day with the dose you took, and its Doctor's report lists each compound's current dose and schedule, so your last shot day and dose are on your phone when the pre-op nurse asks. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1-before-surgery-inline&mt=8)

<!--/promo-->

**Commonly reported:** one clinic saying stop a week ahead and another saying keep going, as hospitals moved to the newer guidance at different speeds; and the clear-liquid day feeling easier than expected, because appetite is already low.

## When do you restart a GLP-1 after surgery?

Only the SPAQI consensus answers it: restart once you are back on your usual diet, at home (grade B) or in hospital (grade E, expert opinion)[7](https://pepvault.app/guides/glp-1-before-surgery#source-7). It warns that stopping can bring the stomach side effects back on restart[7](https://pepvault.app/guides/glp-1-before-surgery#source-7). The 2023 ASA advice and the 2024 multi-society guidance do not cover restarting[5](https://pepvault.app/guides/glp-1-before-surgery#source-5) [6](https://pepvault.app/guides/glp-1-before-surgery#source-6).

Under the labels a held dose is a missed dose, and each label sets its own window for a late shot[1](https://pepvault.app/guides/glp-1-before-surgery#source-1) [2](https://pepvault.app/guides/glp-1-before-surgery#source-2) [3](https://pepvault.app/guides/glp-1-before-surgery#source-3) [4](https://pepvault.app/guides/glp-1-before-surgery#source-4); the missed-dose tool at pepvault.app/tools/missed-glp1-dose quotes each one. A hold plus a slow recovery can trigger one more Wegovy rule: after two or more missed weekly doses in a row, the climb restarts at a lower dose[1](https://pepvault.app/guides/glp-1-before-surgery#source-1). The restart dose is your prescriber's call.

<!--promo-->

Every logged shot keeps its date in PepVault, so the last shot before the break is in your history when you and your prescriber plan the restart. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1-before-surgery-inline&mt=8)

<!--/promo-->

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Novo Nordisk. WEGOVY (semaglutide) injection and tablets, prescribing information, §2.4, §5.10, §12.2, §12.3 and Medication Guide. DailyMed, SPL version 19, June 30, 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
2. Novo Nordisk. OZEMPIC (semaglutide) injection, prescribing information, §2.1, §5.10 and Medication Guide. DailyMed, SPL version 20, June 10, 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79)
3. Eli Lilly and Company. MOUNJARO (tirzepatide) injection, prescribing information, §2.1, §5.9, §10, §12.2, §12.3 and Medication Guide. DailyMed, SPL version 40, September 2, 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0)
4. Eli Lilly and Company. ZEPBOUND (tirzepatide) injection, prescribing information, §2.3, §5.9, §12.2, §12.3 and Medication Guide. DailyMed, SPL version 40 (published September 2, 2026; revised August 2026). [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
5. Joshi GP, Abdelmalak BB, Weigel WA, et al.; ASA Task Force on Preoperative Fasting. American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on glucagon-like peptide-1 (GLP-1) receptor agonists. ASA, June 29, 2023. [asahq.org](https://www.asahq.org/about-asa/newsroom/news-releases/2023/06/american-society-of-anesthesiologists-consensus-based-guidance-on-preoperative)
6. Kindel TL et al.; AGA, ASMBS, ASA, ISPCOP and SAGES. Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period. Surg Endosc. 2025 (online October 2024). [PubMed 39370500](https://pubmed.ncbi.nlm.nih.gov/39370500/)
7. Oprea AD et al. Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement. Br J Anaesth. 2025. [PubMed 40379536](https://pubmed.ncbi.nlm.nih.gov/40379536/)
8. Moore T, Ramsahoye B. Perioperative management of patients taking GLP-1 receptor agonists: a comparative review of international clinical guidelines. Saudi J Anaesth. 2026. [PubMed 42960088](https://pubmed.ncbi.nlm.nih.gov/42960088/)
9. American Society of Anesthesiologists, Made for This Moment. Drugs for diabetes and weight loss (patient page), medically reviewed October 22, 2025. [madeforthismoment.asahq.org](https://madeforthismoment.asahq.org/preparing-for-surgery/risks/drugs-diabetes-weight-loss/)
10. Silveira SQ et al. Relationship between perioperative semaglutide use and residual gastric content: a retrospective analysis of patients undergoing elective upper endoscopy. J Clin Anesth. 2023. [PubMed 36870274](https://pubmed.ncbi.nlm.nih.gov/36870274/)
11. Sen S et al. Glucagon-like peptide-1 receptor agonist use and residual gastric content before anesthesia. JAMA Surg. 2024. [PubMed 38446466](https://pubmed.ncbi.nlm.nih.gov/38446466/)
12. Nersessian RSF et al. Relationship between residual gastric content and peri-operative semaglutide use assessed by gastric ultrasound: a prospective observational study. Anaesthesia. 2024. [PubMed 39435967](https://pubmed.ncbi.nlm.nih.gov/39435967/)
13. Vlaeminck N et al. Gastric ultrasound in patients receiving semaglutide: a prospective, multicentre, matched control study. Anaesthesia. 2026. [PubMed 41631344](https://pubmed.ncbi.nlm.nih.gov/41631344/)
14. Boudreau C et al. Residual gastric content after holding of glucagon-like peptide-1 receptor agonists before elective surgery: a cross-sectional study (the RESIDUAL study). BMC Anesthesiol. 2026. [PubMed 42265610](https://pubmed.ncbi.nlm.nih.gov/42265610/)
15. Pai SL et al.; MAGIC Collaborators. Assessment of gastric content using gastric ultrasound in patients on glucagon-like peptide-1 receptor agonists before anesthesia. Anesth Analg. 2026. [PubMed 41032460](https://pubmed.ncbi.nlm.nih.gov/41032460/)
16. Mendez-Pino L et al. Preoperative fasting status and retained gastric contents in patients undergoing endoscopy who are using glucagon-like peptide type 1 receptor agonists: a multicentre retrospective study. Can J Anaesth. 2026. [PubMed 42618722](https://pubmed.ncbi.nlm.nih.gov/42618722/)
17. Alkabbani W et al. Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study. BMJ. 2024. [PubMed 39438043](https://pubmed.ncbi.nlm.nih.gov/39438043/)
18. Dixit AA et al. Preoperative GLP-1 receptor agonist use and risk of postoperative respiratory complications. JAMA. 2024. [PubMed 38648036](https://pubmed.ncbi.nlm.nih.gov/38648036/)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)

Diarrhea on Ozempic, Wegovy, Mounjaro and Zepbound: each label's rate by dose against placebo, when it starts, how long a bout lasts, and what helps.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)

## Related guides

- Guide · GLP-1s

  ### [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)

  What happened to weight when semaglutide and tirzepatide were stopped in STEP 1, STEP 4 and SURMOUNT-4: how much came back, how fast, and what the labels say.

  Read the guide
- Guide · GLP-1s

  ### [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)

  Wegovy and Ozempic dosage side by side: both FDA labels' four-week steps, the maintenance doses and the max, why they differ and what the trials saw per dose.

  Read the guide
- Guide · GLP-1s

  ### [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)

  Tirzepatide doses from 2.5 to 15 mg: the Mounjaro and Zepbound label steps, the 4-week rule, maintenance doses, pens and vials, and SURMOUNT-1 weight by dose.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
